Literature DB >> 33106046

Reducing Psychological Reactance to Health Promotion Messages: Comparing Preemptive and Postscript Mitigation Strategies.

Adam S Richards1, Elena Bessarabova2, John A Banas2, Daniel R Bernard3.   

Abstract

This study compared the relative efficacy of two strategies designed to mitigate psychological reactance in health campaigns by using reminders of behavioral autonomy: preemptive scripts, which appear before the appeal, and restoration postscripts, which appear after. Employing a mixed-model experiment with a 2 (threat to freedom: low vs. high) × 3 (reactance-mitigation strategy: control vs. preemptive script vs. restoration postscript) × 2 (health campaign topic: exercise vs. nutrition) between-subjects design and a within-subjects factor of time (immediate posttest measurement followed by a one-week delay), this study (N = 394) compared the effects of the two mitigation strategies on reactance, attitude, and behavioral intention at two points in time. Moderated mediation models indicated that the reactance-mitigation strategies equivalently reduced the degree to which reactance was experienced in response to increasingly threatening health appeals (relative to the control). This effect indirectly influenced behavioral intention via attitude change and remained after one week.

Entities:  

Mesh:

Year:  2020        PMID: 33106046     DOI: 10.1080/10410236.2020.1839203

Source DB:  PubMed          Journal:  Health Commun        ISSN: 1041-0236


  2 in total

1.  African American Parents' Perceived Vaccine Efficacy Moderates the Effect of Message Framing on Psychological Reactance to HPV Vaccine Advocacy.

Authors:  Adam S Richards; Yan Qin; Kelly Daily; Xiaoli Nan
Journal:  J Health Commun       Date:  2021-08-24

2.  Participant Engagement and Reactance to a Short, Animated Video About Added Sugars: Web-based Randomized Controlled Trial.

Authors:  Caterina Favaretti; Alain Vandormael; Violetta Hachaturyan; Merlin Greuel; Jennifer Gates; Till Bärnighausen; Maya Adam
Journal:  JMIR Public Health Surveill       Date:  2022-01-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.